Ron D. Henriksen

QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.

PreMD, Inc. engages in manufacturing and distribution of pharmaceutical products. The company was founded by H. B. Brent Norton on November 9, 1992 and is headquartered in Toronto, Canada.

EndGenitor Technologies, Inc. commercialized adult stem cell products. It was an adult stem cell company, and the outcome of its studies may support the filing of regulatory applications for clinical trials for human disease and tissue dysfunction. The company was founded by Ronald D. Henriksen, Carlos Lopez, Merv Yonder and Dave Ingram in 2005 and was headquartered in Indianapolis, IN.

Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN.

BioStorage Technologies, Inc. provides biological sample storage, DNA storage, shipping, tracking and reporting services. The firm provides sample management consulting, supply chain, logistics, relocation, preparation, storage, and business continuity consulting and disaster recovery services. It offers onsite, offsite and hybrid sample outsourcing models for the management of sample assets. The company was founded by F. John Mills and Oscar Moralez in 2002 and is headquartered in Indianapolis, IN.

Part of Quest Diagnostics, Inc., Khepri Pharmaceuticals, Inc. is a developer of pharmaceutical products. The company is based in South San Francisco, CA. The company was founded by Donald G. Payan. Khepri Pharmaceuticals was acquired by Arris Pharmaceutical Corp. on December 26, 1995 for $33.40 million.